08:00 , Mar 4, 2013 |  BC Week In Review  |  Company News

Organovo Holdings, Zen-Bio Inc. deal

The companies partnered to produce 3D human tissue models for drug discovery and advanced tissue therapies. Zen-Bio will provide validated human cellular inputs for use in Organovo's NovoGen bioprinting technology. The partners declined to disclose...
07:00 , Oct 17, 2011 |  BC Week In Review  |  Company News

Cyntellect, GT Life Sciences Inc., Intrexon deal

Synthetic biology company Intrexon said it acquired GT Life Sciences as well as Cyntellect's LEAP high throughput cell analysis and laser-based cell manipulation technology. Intrexon simultaneously launched its Cell Engineering Unit (CEU) to support the...
07:00 , May 16, 2011 |  BioCentury  |  Finance

Healing Biotech IPOS?

Healing biotech IPOs? Profitable wound healing play Advanced BioHealing Inc. is trying to pull off what would be the largest biotech IPO this year. It expects to get the offering done this week. Prior to launching its...
08:00 , Feb 28, 2011 |  BioCentury  |  Finance

Dermagraft redux

Profitable wound healing play Advanced BioHealing Inc. proposed late Friday to raise up to $200 million in an IPO. The company markets Dermagraft, a human fibroblast-derived skin substitute, to treat full-thickness diabetic foot ulcers. Last November, Advanced...
07:00 , May 5, 2008 |  BioCentury  |  Emerging Company Profile

Histogen: Regenerating tissue science

Despite having approved products, many of the first wave of tissue regeneration companies were unable to surmount manufacturing and reimbursement obstacles to become sustainable businesses. Histogen Inc. thinks it has solved both sets of problems...
07:00 , May 24, 2004 |  BC Week In Review  |  Company News

Iken Tissue Therapeutics Inc. deal

Iken entered into an agreement to acquire Anginera from the trustee of the liquidating trust of Advanced Tissue Sciences. Iken will pay the trust $200,000 upon closing, plus milestones of $300,000 when a human...
08:00 , Mar 17, 2003 |  BC Week In Review  |  Clinical News

CosmoDerm human-based collagen product regulatory update

The FDA granted marketing approval for ATIS partner IMDC’s premarket approval (PMA) supplement for CosmoDerm, a human-based collagen product as a dermal filler for wrinkles. ATIS said the approval triggers a $2 million payment from...
08:00 , Dec 9, 2002 |  BC Week In Review  |  Company News

Advanced Tissue, Smith & Nephew deal

ATIS completed the previously announced sale of its interest in the Dermagraft joint venture to JV partner SNN. ATIS said it received net proceeds of $7 million. Dermagraft is a dermal replacement used to...
08:00 , Nov 25, 2002 |  BioCentury  |  Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Notes Cash Years cash pre-cut Cash reporting date 11/13 Advanced Tissue (ATIS) NA After filing for Chapter 11 in October, ATIS's board unanimously elected to liquidate the company's assets....
08:00 , Nov 4, 2002 |  BioCentury  |  Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Notes Cash Years cash pre-cut Cash reporting date 10/29 Abgenix (ABGX) 15% to about 386 Plans to partner its therapeutic antibodies when they are in...